# Filing Detail

Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001640334-17-000063
Filing Date
2017-01-11
Accepted
2017-01-10 21:36:08
Documents
26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B3 | nmus_424b3.htm | 424B3 | 423835
2 |  | nmus_424b3img7.jpg | GRAPHIC | 103494
3 |  | nmus_424b3img8.jpg | GRAPHIC | 139179
4 |  | nmus_424b3img9.jpg | GRAPHIC | 150065
5 |  | nmus_424b3img1.jpg | GRAPHIC | 8789
6 |  | nmus_424b3img10.jpg | GRAPHIC | 126210
7 |  | nmus_424b3img11.jpg | GRAPHIC | 144523
8 |  | nmus_424b3img12.jpg | GRAPHIC | 142438
9 |  | nmus_424b3img13.jpg | GRAPHIC | 143096
10 |  | nmus_424b3img14.jpg | GRAPHIC | 157990
11 |  | nmus_424b3img15.jpg | GRAPHIC | 144021
12 |  | nmus_424b3img16.jpg | GRAPHIC | 152698
13 |  | nmus_424b3img17.jpg | GRAPHIC | 156830
14 |  | nmus_424b3img18.jpg | GRAPHIC | 148758
15 |  | nmus_424b3img19.jpg | GRAPHIC | 133282
16 |  | nmus_424b3img2.jpg | GRAPHIC | 9174
17 |  | nmus_424b3img20.jpg | GRAPHIC | 145438
18 |  | nmus_424b3img21.jpg | GRAPHIC | 136850
19 |  | nmus_424b3img22.jpg | GRAPHIC | 38787
20 |  | nmus_424b3img23.jpg | GRAPHIC | 50370
21 |  | nmus_424b3img24.jpg | GRAPHIC | 71641
22 |  | nmus_424b3img25.jpg | GRAPHIC | 10865
23 |  | nmus_424b3img3.jpg | GRAPHIC | 101533
24 |  | nmus_424b3img4.jpg | GRAPHIC | 92928
25 |  | nmus_424b3img5.jpg | GRAPHIC | 96635
26 |  | nmus_424b3img6.jpg | GRAPHIC | 92087
| Complete submission text file | 0001640334-17-000063.txt |  | 4143107

Mailing Address 600 ANTON BLVD, SUITE 1100 COSTA MESA CA 92626
Business Address 600 ANTON BLVD, SUITE 1100 COSTA MESA CA 92626 (949) 396-0330
Nemus Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

EIN.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-206992 | Film No.: 17521867
SIC: 2834 Pharmaceutical Preparations